Published in J Infect Dis on March 01, 1986
The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med (1994) 2.26
Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol (1993) 2.04
Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol (1992) 1.99
Thymic involution and immune reconstitution. Trends Immunol (2009) 1.91
Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe (2010) 1.77
Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol (1997) 1.71
Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol (2001) 1.65
Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest (1997) 1.62
An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection. J Virol (1993) 1.46
Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). J Virol (1992) 1.42
PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. J Clin Invest (2009) 1.37
Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy. Biol Blood Marrow Transplant (2009) 1.35
Evaluation of a direct fluorescein-conjugated monoclonal antibody for detection of cytomegalovirus in centrifugation culture. J Clin Microbiol (1987) 1.35
The history of cytomegalovirus and its diseases. Med Microbiol Immunol (2007) 1.32
Increase in severity of graft versus host disease by cytomegalovirus. J Clin Pathol (1992) 1.25
Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J Virol (2003) 1.21
Detection of cytomegalovirus in peripheral leukocytes by different methods. J Clin Microbiol (1989) 1.18
The status of CMV as a human pathogen. Epidemiol Infect (1988) 1.17
Novel DNA assay for cytomegalovirus detection: comparison with conventional culture and pp65 antigenemia assay. J Clin Microbiol (1996) 1.17
Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. Biol Blood Marrow Transplant (2009) 1.16
The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression. J Clin Invest (1994) 1.15
CMV enteritis causing ileal perforation in underlying lupus enteritis. Clin Rheumatol (2003) 1.15
Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation. J Clin Microbiol (2000) 1.13
Detection of cytomegalovirus from clinical specimens in centrifugation culture by in situ DNA hybridization and monoclonal antibody staining. J Clin Microbiol (1989) 1.11
The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis. Infect Disord Drug Targets (2011) 1.10
Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor. Front Immunol (2013) 1.06
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants. Clin Microbiol Rev (2003) 1.06
Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J Virol (1994) 1.05
Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J Virol (1997) 1.05
Detection of CMV DNA in bone marrow transplant recipients: plasma versus leucocyte polymerase chain reaction. J Clin Pathol (1997) 1.04
Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J Clin Microbiol (1994) 1.00
Evaluation of four methods for cytomegalovirus antibody detection for use by a bone marrow transplantation service. J Clin Microbiol (1989) 0.98
Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood (2007) 0.96
Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma. Ann Hematol (1992) 0.94
Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients. Biol Blood Marrow Transplant (2012) 0.93
Evaluation of Murex CMV DNA hybrid capture assay for detection and quantitation of cytomegalovirus infection in patients following allogeneic stem cell transplantation. J Clin Microbiol (1998) 0.93
Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro. Antimicrob Agents Chemother (1990) 0.91
Evaluation of a latex particle agglutination assay for the detection of cytomegalovirus antibody in patient serum. J Clin Microbiol (1989) 0.90
Bench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentation. Crit Care (2008) 0.90
Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins. PLoS One (2012) 0.89
Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant (2010) 0.88
Monitoring of leukocyte cytomegalovirus DNA in bone marrow transplant recipients by nested PCR. J Clin Microbiol (1995) 0.88
Human cytomegalovirus infection. Thorax (1989) 0.88
The pulmonary complications of bone marrow transplantation in adults. West J Med (1989) 0.88
Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification. J Clin Microbiol (2000) 0.87
Kinetics of effector functions and phenotype of virus-specific and γδ T lymphocytes in primary human cytomegalovirus infection during pregnancy. J Clin Immunol (2011) 0.87
Real-time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patients. J Clin Microbiol (2003) 0.85
Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev (1997) 0.85
Evaluation of the CMV-CUBE assay for detection of cytomegalovirus serologic status in marrow transplant patients and marrow donors. J Clin Microbiol (1990) 0.85
Detection of cytomegalovirus antigens and DNA in tissues fixed in formaldehyde. J Clin Pathol (1989) 0.83
Human Cytomegalovirus (HCMV) - Revised. Transfus Med Hemother (2010) 0.83
Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis. Emerg Infect Dis (2011) 0.83
Mesenchymal stem cells engineered to inhibit complement-mediated damage. PLoS One (2013) 0.82
Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice. Antimicrob Agents Chemother (1989) 0.82
In vitro hydroxyurea decreases Th1 cell-mediated immunity. Clin Diagn Lab Immunol (2001) 0.81
Virus infections in bone marrow transplant recipients: a three year prospective study. J Clin Pathol (1990) 0.80
Current and Potential Treatments for Ubiquitous but Neglected Herpesvirus Infections. Chem Rev (2014) 0.80
Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential. Front Immunol (2012) 0.80
Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients. Pharmacotherapy (2010) 0.80
VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice. PLoS One (2013) 0.79
Bone marrow transplantation: a review. J Natl Med Assoc (1989) 0.79
Cytomegalovirus and marrow function. Ann Hematol (1992) 0.78
Active human cytomegalovirus infection and glycoprotein b genotypes in brazilian pediatric renal or hematopoietic stem cell transplantation patients. Braz J Microbiol (2010) 0.78
Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant (2014) 0.78
Risk factors for viral reactivation following bone marrow transplantation. Ann Hematol (1992) 0.78
Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis. Clin Rheumatol (2005) 0.78
Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. Clin Exp Immunol (1994) 0.76
Risk factors of clinically refractory CMV reactivation following allogeneic HSCT: a single-center study in China. Bone Marrow Transplant (2016) 0.75
A cross-Canada survey of cytomegalovirus prevention and treatment practices in bone marrow transplant recipients. Can J Infect Dis (1999) 0.75
Determination of human cytomegalovirus pp65 antigenemia among renal transplant patients. Indian J Nephrol (2012) 0.75
Cytomegalovirus infection complicating immunosuppressive treatment. Postgrad Med J (1988) 0.75
Enhanced Induction of T Cell Immunity Using Dendritic Cells Pulsed with HIV Tat and HCMV-pp65 Fusion Protein In Vitro. Immune Netw (2011) 0.75
Cytomegalovirus pneumonitis and bone marrow transplantation: identification of a specific high risk group. J Clin Pathol (1993) 0.75
Impaired expression of interleukin 2 receptor and CD45RO antigen on lymphocytes from children with acute lymphoblastic leukemia in response to cytomegalovirus and varicella-zoster virus. Clin Diagn Lab Immunol (1995) 0.75
Correlation of pretransplant viral serology and complications of bone marrow transplantation. Ann Hematol (1992) 0.75
Intestinal perforation due to hemorrhagic Cytomegalovirus enteritis in a patient with severe uncontrolled lupus nephritis: a case and review of the literature. Rheumatol Int (2017) 0.75
Prevention of viral infections after bone marrow transplantation. Ann Hematol (1992) 0.75
Prevention and treatment of CMV infection after allogeneic bone marrow transplant. Ann Hematol (1992) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
The analysis of failure times in the presence of competing risks. Biometrics (1978) 11.22
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med (1995) 10.04
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 3.59
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Iron Metabolism. Heme Synthesis in Vitro by Immature Erythrocytes. Science (1949) 3.14
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med (1990) 2.66
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis (1983) 2.39
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis (1990) 2.39
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med (1985) 2.30
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia. Ann Intern Med (1985) 2.28
Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol (1988) 2.24
Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med (1985) 2.23
Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. J Infect Dis (1995) 2.20
Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology (1984) 2.19
Diagnosis of cytomegaloviral pneumonia by in situ hybridization. J Infect Dis (1984) 2.18
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet (1972) 2.13
A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis (1977) 2.10
Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature (1987) 2.04
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med (1993) 2.01
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med (1986) 1.99
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood (1994) 1.98
Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med (1991) 1.96
Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol (1990) 1.91
Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med (1983) 1.89
The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology (1980) 1.88
Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med (1993) 1.84
Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood (1992) 1.83
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Technique for human marrow grafting. Blood (1970) 1.83
Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80
Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1971) 1.79
Infection with varicella-zoster virus after marrow transplantation. J Infect Dis (1985) 1.77
Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med (1988) 1.77
Allogeneic marrow grafting for treatment of aplastic anemia. Blood (1974) 1.76
Bone marrow grafts and tolerance. Nature (1986) 1.74
Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med (1988) 1.72
Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol (1988) 1.72
Marrow transplantation for thalassaemia. Lancet (1982) 1.71
An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis (1992) 1.69
Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med (1982) 1.67
Giardia lamblia infection in homosexual men. Br J Vener Dis (1977) 1.65
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood (1987) 1.63
Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant. J Infect Dis (1991) 1.62
Shigellosis at sea: an outbreak aboard a passenger cruise ship. Am J Epidemiol (1975) 1.60
Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet (1984) 1.60
Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation (1974) 1.58
The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol (1977) 1.58
Hemophilia: role of organ homografts. Science (1969) 1.56
Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med (1981) 1.56
Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol (1979) 1.55
Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med (1977) 1.55
Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection. Oral Surg Oral Med Oral Pathol (1990) 1.51
Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. J Infect Dis (1992) 1.50
Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation (1973) 1.48
Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med (1967) 1.46
Bone marrow transplantation in acute leukemia. Cancer Res (1965) 1.46
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med (1983) 1.44
Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody. J Infect Dis (1985) 1.44
Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med (1979) 1.44
Cytomegalovirus infection in sex partners: evidence for sexual transmission. J Infect Dis (1985) 1.42
Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med (1982) 1.41
Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med (1986) 1.41